Figure 2 | Molecular Psychiatry

Figure 2

From: Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

Figure 2

Primary and secondary endpoints: the top panel shows the measures on the primary end points of weight, fat mass and binge-eating scale scores. The change in overall hedonic response to sweetened dairy products and the buffet intake are depicted in the middle panel. The bottom panel shows hedonic responses to high-fat and high-sugar concentrations and intake of the high-fat desserts.

PowerPoint slide

Back to article page